MKI67 and breast carcinoma: Previous studies have indicated that the level of Ki67 is an independent prognostic factor of breast cancer-specific survival (BCSS) and DFS in breast cancer patients (23, 24), and our study confirmed the value of the level of Ki67 in prediction of survival in small-sized tumor patients.